LV12633B - REGULATORY AGENT FOR THE RETINOIC PREPARATOR'S FUNCTION - Google Patents
REGULATORY AGENT FOR THE RETINOIC PREPARATOR'S FUNCTION Download PDFInfo
- Publication number
- LV12633B LV12633B LVP-00-177A LV000177A LV12633B LV 12633 B LV12633 B LV 12633B LV 000177 A LV000177 A LV 000177A LV 12633 B LV12633 B LV 12633B
- Authority
- LV
- Latvia
- Prior art keywords
- group
- optionally substituted
- hydrogen
- hydrocarbon group
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18669898 | 1998-07-01 | ||
| PCT/JP1999/003520 WO2000001679A1 (fr) | 1998-07-01 | 1999-06-30 | Regulateurs du recepteur associe aux retinoides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV12633A LV12633A (lv) | 2001-03-20 |
| LV12633B true LV12633B (en) | 2001-07-20 |
Family
ID=16193077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-00-177A LV12633B (en) | 1998-07-01 | 2000-12-28 | REGULATORY AGENT FOR THE RETINOIC PREPARATOR'S FUNCTION |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6545009B1 (ko) |
| EP (1) | EP1092711A4 (ko) |
| KR (1) | KR20010053282A (ko) |
| CN (1) | CN1314899A (ko) |
| AU (1) | AU4394799A (ko) |
| BR (1) | BR9911752A (ko) |
| CA (1) | CA2332178A1 (ko) |
| HU (1) | HUP0102470A3 (ko) |
| ID (1) | ID29247A (ko) |
| IL (1) | IL140422A0 (ko) |
| LV (1) | LV12633B (ko) |
| NO (1) | NO20006667L (ko) |
| PL (1) | PL345247A1 (ko) |
| SK (1) | SK20182000A3 (ko) |
| WO (1) | WO2000001679A1 (ko) |
| ZA (1) | ZA200007635B (ko) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548529B1 (en) | 1999-04-05 | 2003-04-15 | Bristol-Myers Squibb Company | Heterocyclic containing biphenyl aP2 inhibitors and method |
| AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
| EP1394154A4 (en) * | 2001-03-23 | 2005-05-18 | Takeda Pharmaceutical | HETEROCYCLIC DERIVATIVE WITH FIVE MEMBERS OF ALKANOIC ACID |
| WO2002085382A1 (en) * | 2001-04-18 | 2002-10-31 | Genzyme Corporation | Methods of treating syndrome x with aliphatic polyamines |
| GB0112348D0 (en) * | 2001-05-19 | 2001-07-11 | Smithkline Beecham Plc | Compounds |
| US20040248863A1 (en) * | 2001-06-22 | 2004-12-09 | Wright Samuel D. | Combination of a ppar-alpha ligand and glucocorticoid for the treatment or prevention of inflamation |
| JP2003081832A (ja) * | 2001-06-26 | 2003-03-19 | Takeda Chem Ind Ltd | レチノイド関連受容体機能調節剤 |
| EP1405636A4 (en) * | 2001-06-26 | 2009-04-15 | Takeda Pharmaceutical | REGULATOR OF RECTINTOR FUNCTION RELATING TO RETINOIDS |
| ATE352312T1 (de) * | 2001-12-29 | 2007-02-15 | Novo Nordisk As | Kombinierte verwendung einer glp-1-verbindung und eines aldose reduktase inhibitors |
| US7183276B2 (en) | 2002-02-28 | 2007-02-27 | Takeda Pharmaceutical Company Limited | Azole compounds |
| BR0315815A (pt) | 2002-11-01 | 2005-09-13 | Takeda Pharmaceutical | Agentes para prevenir ou tratar neuropatia, para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor, neuroprotetor e farmacêutico, composto, métodos para prevenir ou tratar neuropatia e para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor para proteger um nervo em um mamìfero e para produzir um composto e uso de um composto |
| GB0303503D0 (en) * | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
| DE10308353A1 (de) * | 2003-02-27 | 2004-12-02 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US20090054493A1 (en) * | 2005-02-25 | 2009-02-26 | Heonjoong Kang Kang | Thiazole derivatives as ppar delta ligands and their manufacturing process |
| CA2599281C (en) * | 2005-02-25 | 2012-01-17 | Heonjoong Kang | Thiazole derivatives as ppar delta ligands and their manufacturing process |
| KR20080066938A (ko) * | 2005-10-07 | 2008-07-17 | 깃세이 야쿠힌 고교 가부시키가이샤 | 질소 함유 복소환 화합물 및 그것을 함유하는 의약 조성물 |
| WO2008064136A2 (en) * | 2006-11-17 | 2008-05-29 | Acadia Pharmaceuticals Inc. | Compounds with activity at retinoic acid receptors |
| US9085566B2 (en) | 2007-02-02 | 2015-07-21 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic and related disorders |
| US8207196B2 (en) | 2007-02-02 | 2012-06-26 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic disorders |
| US9187485B2 (en) | 2007-02-02 | 2015-11-17 | Baylor College Of Medicine | Methods and compositions for the treatment of cancer and related hyperproliferative disorders |
| US9212179B2 (en) | 2007-02-02 | 2015-12-15 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic disorders |
| US9233941B2 (en) | 2007-02-02 | 2016-01-12 | Baylor College Of Medicine | Methods and compositions for the treatment of body weight related disorders |
| CN104054719B (zh) | 2007-08-13 | 2016-09-28 | 孟山都技术有限责任公司 | 用于控制线虫的组合物和方法 |
| WO2011011105A2 (en) * | 2009-05-07 | 2011-01-27 | Baylor College Of Medicine | Traceable retinoid acid for imaging, disease prevention and therapy |
| GB0915196D0 (en) | 2009-09-01 | 2009-10-07 | King S College London | Therapeutic compounds and their use |
| WO2012028100A1 (en) * | 2010-09-01 | 2012-03-08 | Glaxo Group Limited | Novel compounds |
| MX2017008090A (es) * | 2014-12-19 | 2017-12-04 | Galderma Res & Dev | Nuevos compuestos, su procedimiento de sintesis y su uso en medicina, asi como en cosmetica. |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
| US10865793B2 (en) | 2016-12-06 | 2020-12-15 | Air Squared, Inc. | Scroll type device having liquid cooling through idler shafts |
| US20200025199A1 (en) | 2018-07-17 | 2020-01-23 | Air Squared, Inc. | Dual drive co-rotating spinning scroll compressor or expander |
| US11530703B2 (en) | 2018-07-18 | 2022-12-20 | Air Squared, Inc. | Orbiting scroll device lubrication |
| US11898557B2 (en) | 2020-11-30 | 2024-02-13 | Air Squared, Inc. | Liquid cooling of a scroll type compressor with liquid supply through the crankshaft |
| US11885328B2 (en) | 2021-07-19 | 2024-01-30 | Air Squared, Inc. | Scroll device with an integrated cooling loop |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4001420A (en) | 1968-12-12 | 1977-01-04 | Science Union Et Cie, Societe Francaise De Recherche Medical | Thiazolyl benzoic acid compounds |
| GB1308028A (en) | 1970-06-12 | 1973-02-21 | Science Union & Cie | Thiazolylbenzoic acid derivatives and a process for their manufactur |
| JPS4932853A (ko) | 1972-07-27 | 1974-03-26 | ||
| US3939115A (en) * | 1974-10-02 | 1976-02-17 | Eastman Kodak Company | Polychromophoric ultraviolet stabilizers and their use in organic compositions |
| US4043973A (en) | 1974-10-02 | 1977-08-23 | Eastman Kodak Company | Multichromophoric ultraviolet stabilizers for organic compositions |
| US4164480A (en) | 1978-01-09 | 1979-08-14 | Eastman Kodak Company | Polychromophoric ultraviolet stabilizers and their use in organic compositions |
| SU1078859A1 (ru) | 1982-03-31 | 1997-10-20 | Б.М. Красовицкий | 2-(5-фенилоксазолил-2)-5-(5-арилоксазолил-2)-бензойные кислоты в качестве органических люминофоров сине-зеленого свечения в органических растворителях и водной среде |
| JPH0725754B2 (ja) * | 1986-01-30 | 1995-03-22 | 富山化学工業株式会社 | 新規なチアゾール化合物またはその塩 |
| JP2524786B2 (ja) * | 1987-12-15 | 1996-08-14 | コニカ株式会社 | 直接ポジハロゲン化銀カラ―写真感光材料 |
| DE3903993A1 (de) | 1989-02-10 | 1990-08-16 | Basf Ag | Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus |
| JP2941937B2 (ja) | 1990-01-25 | 1999-08-30 | キヤノン株式会社 | 新規化合物、これを含む液晶組成物及びこれを使用した液晶素子並びに表示装置 |
| JPH04154773A (ja) * | 1990-10-15 | 1992-05-27 | Green Cross Corp:The | チアゾール誘導体 |
| JP2829451B2 (ja) * | 1990-11-30 | 1998-11-25 | 大塚製薬株式会社 | 活性酸素抑制剤 |
| JP3385387B2 (ja) * | 1992-05-29 | 2003-03-10 | 大塚製薬株式会社 | チアゾール誘導体 |
| US5639770A (en) | 1992-05-29 | 1997-06-17 | Otsuka Pharmaceutical Co., Ltd. | Thiazole derivatives |
| US5342851A (en) | 1992-10-07 | 1994-08-30 | Mcneil-Ppc, Inc. | Substituted thiazole derivatives useful as platelet aggregation inhibitors |
| DE4302051A1 (de) * | 1993-01-26 | 1994-07-28 | Thomae Gmbh Dr K | 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| ES2255073T3 (es) | 1995-02-24 | 2006-06-16 | Basf Aktiengesellschaft | Derivados de pirazol-4-il-benzoilo y su empleo como herbicidas. |
| JP3964478B2 (ja) * | 1995-06-30 | 2007-08-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬 |
| JP3865829B2 (ja) | 1995-09-21 | 2007-01-10 | 株式会社医薬分子設計研究所 | レチノイド作用増強性化合物 |
| ES2124167B1 (es) | 1996-06-04 | 1999-09-16 | Espanola Prod Quimicos | Nuevos derivados del bencimidazol con actividad antihistaminica. |
| AU4015497A (en) | 1996-08-26 | 1998-03-19 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Thiazole derivatives useful as selective inhibitors of pde-iv |
| JP4300373B2 (ja) * | 1996-09-30 | 2009-07-22 | 大塚製薬株式会社 | サイトカイン産生抑制剤及び接着抑制剤 |
| AUPO691897A0 (en) * | 1997-05-21 | 1997-06-12 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
-
1999
- 1999-06-30 AU AU43947/99A patent/AU4394799A/en not_active Abandoned
- 1999-06-30 CA CA002332178A patent/CA2332178A1/en not_active Abandoned
- 1999-06-30 EP EP99926853A patent/EP1092711A4/en not_active Withdrawn
- 1999-06-30 KR KR1020007014995A patent/KR20010053282A/ko not_active Application Discontinuation
- 1999-06-30 BR BR9911752-5A patent/BR9911752A/pt not_active Application Discontinuation
- 1999-06-30 PL PL99345247A patent/PL345247A1/xx not_active Application Discontinuation
- 1999-06-30 US US09/720,644 patent/US6545009B1/en not_active Expired - Fee Related
- 1999-06-30 IL IL14042299A patent/IL140422A0/xx unknown
- 1999-06-30 HU HU0102470A patent/HUP0102470A3/hu unknown
- 1999-06-30 CN CN99810103A patent/CN1314899A/zh active Pending
- 1999-06-30 ID IDW20010004D patent/ID29247A/id unknown
- 1999-06-30 SK SK2018-2000A patent/SK20182000A3/sk unknown
- 1999-06-30 WO PCT/JP1999/003520 patent/WO2000001679A1/ja not_active Application Discontinuation
-
2000
- 2000-12-19 ZA ZA200007635A patent/ZA200007635B/en unknown
- 2000-12-27 NO NO20006667A patent/NO20006667L/no not_active Application Discontinuation
- 2000-12-28 LV LVP-00-177A patent/LV12633B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1314899A (zh) | 2001-09-26 |
| PL345247A1 (en) | 2001-12-03 |
| WO2000001679A1 (fr) | 2000-01-13 |
| EP1092711A1 (en) | 2001-04-18 |
| LV12633A (lv) | 2001-03-20 |
| NO20006667L (no) | 2001-02-28 |
| SK20182000A3 (sk) | 2001-08-06 |
| BR9911752A (pt) | 2001-04-03 |
| EP1092711A4 (en) | 2002-07-31 |
| IL140422A0 (en) | 2002-02-10 |
| KR20010053282A (ko) | 2001-06-25 |
| ZA200007635B (en) | 2002-01-02 |
| HUP0102470A2 (hu) | 2002-04-29 |
| US6545009B1 (en) | 2003-04-08 |
| CA2332178A1 (en) | 2000-01-13 |
| ID29247A (id) | 2001-08-16 |
| AU4394799A (en) | 2000-01-24 |
| NO20006667D0 (no) | 2000-12-27 |
| HUP0102470A3 (en) | 2002-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV12633B (en) | REGULATORY AGENT FOR THE RETINOIC PREPARATOR'S FUNCTION | |
| EP1228067B1 (en) | 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity | |
| EP1357115B1 (en) | Alkanoic acid derivatives, process for their production and use thereof | |
| AU766831B2 (en) | Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity | |
| US20040063775A1 (en) | Five-membered heterocyclic alkanoic acid derivative | |
| US20040157881A1 (en) | Function regulator for retinoid relative receptor | |
| JP4148681B2 (ja) | アルカン酸誘導体、その製造法および用途 | |
| EP1229026A1 (en) | Alkoxyiminoalkanoic acid derivatives | |
| JP2000080086A (ja) | レチノイド関連受容体機能調節剤 | |
| MXPA00012925A (en) | Retinoid-associated receptor regulators | |
| CZ20004879A3 (cs) | Činidlo regulující funkci receptoru souvisejícího s retinoidy | |
| MXPA00010576A (en) | Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity | |
| ZA200203824B (en) | 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity. | |
| CZ20004104A3 (cs) | Deriváty kyseliny oxyiminoalkanové |